Early Occupational Therapy for Delirium Prevention in Older Patients Admitted to Critical Care Unit

May 19, 2014 updated by: Evelyn Alvarez Espinoza, OT, Principal Investigator, University of Chile

Early Occupational Therapy (OT) for Delirium Prevention in Older Patients Admitted to Critical Care Unit (CCU)

This is a randomized, controlled trial to compare the efficacy of two strategies of non-pharmacological prevention of delirium in critically non-ventilated older patients:

  • standard non-pharmacological prevention
  • intensive nonpharmacological prevention (standard non-pharmacological prevention plus early and intensive occupational therapy).

Study Overview

Detailed Description

Delirium is a complication in older, with incidences 70-87% in CCU. This increases mortality, hospital stay, hospital cost, and cognitive impairment. Occupational Therapy (OT) improves independence at discharge, and reduction in delirium in patients undergoing mechanical ventilation. This study compares the efficacy of non pharmacological standard prevention (control group) versus intensive nonpharmacological prevention (experimental group) in the delirium duration in older admitted CCU.

Study Type

Interventional

Enrollment (Actual)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • RM
      • Santiago, RM, Chile
        • Hospital Clínico Universidad de Chile

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 95 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age over 60 years.
  • Admission to CCU for monitoring by acute or chronic illness, expected more than 24 hours
  • Informed consent of patient or family related.

Exclusion Criteria:

  • Cognitive impairment before to admission (measured by Test Reporter-TIN).
  • Severe disorder of communication and cultural constraint of language (inhability of properly communicating in Spanish)
  • Delirium at CCU admission or at the beginning of the intervention
  • Need for mechanical ventilation
  • Early limitation of therapeutic efforts and greater comorbidity with expected mortality within 90 days (in the opinion of the treating team).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Early and intensive OT

Intervention group:Standard non-pharmacological prevention plus early and intensive OT. Begin in the first 24 hours in CCU admission. OT areas:1)Multi-sensory stimulation:Intense external stimulation, increase alertness,2)Positioning: Fixtures like dorxi-flexion splints, devices for preventing edema,etc,3)Cognitive Stimulation: Awareness, orientation, attention, memory, calculation, praxis and language,4)Training Activities of Daily Living (ADL): Keep a daily routine and independence in hygiene, grooming and feeding,5)Upper Limb Motor Stimulation (ULMS): Activate functional movement and strength ,6)Family involvement.

General Guidelines for intervention: Visit of an OT twice a day, 40 minutes each time, for 5 days; meeting of family training for promote strategies during the daily visit.

Other Names:
  • Active hospital routine
ACTIVE_COMPARATOR: Standard non-pharmacological prevention
Non-pharmacological strategies are the first line of approach in the prevention of delirium. It is recommended to implement some of these strategies, which are: Reorientation protocol, including information 4 times a day about time, date, place and reason for hospitalization; early mobilization by physical therapist 3 times a day, corrected sensory impairment (use such as eyeglasses, hearing aids); environment management, use clock and calendar in the patient´s room, promote supervision of a professional or family to avoid physical restraints; sleep protocol, like lower light, noise and nighttime drug administration and finally, reduction of any anticholinergic drugs and minimize the use of benzodiazepines.
Other Names:
  • Recommended non-pharmacological treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate Delirium duration
Time Frame: From second until sixth days hospitalization
Twice a day evaluation for delirium with CAM instrument, for 5 days from enrollment
From second until sixth days hospitalization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delirium incidence
Time Frame: From second until sixth days hospitalization
Proportion of patients in each arm, to developed delirium during daily evaluation
From second until sixth days hospitalization
Functional independence
Time Frame: To seventh day of hospitalization and 72 hours before discharge
Comparing performance of Activity Daily Living (ADL) at hospital discharge compared to baseline, using FIM (Functional Independence Measure) instrument
To seventh day of hospitalization and 72 hours before discharge
Strenght of Grip evaluation
Time Frame: To seventh day of hospitalization and 72 hours before discharge
Strength of grip by Jamar Dynamometer, is evaluated to hospitalary discharge
To seventh day of hospitalization and 72 hours before discharge
Cognitive State
Time Frame: To seventh day of hospitalization and 72 hours before discharge
MMSE (Mini-Mental State Examination), evaluates cognitive state at hospital discharge
To seventh day of hospitalization and 72 hours before discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Evelyn Alvarez, University of Chile
  • Study Chair: Maricel Garrido, University of Chile
  • Study Chair: Eduardo Tobar, University of Chile
  • Study Chair: Rolando Aranda, University of Chile

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (ACTUAL)

July 1, 2012

Study Completion (ACTUAL)

December 1, 2012

Study Registration Dates

First Submitted

January 10, 2012

First Submitted That Met QC Criteria

March 15, 2012

First Posted (ESTIMATE)

March 16, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

May 21, 2014

Last Update Submitted That Met QC Criteria

May 19, 2014

Last Verified

May 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on Early and Intensive Occupational Therapy

3
Subscribe